Mechanism of Action | ARIKAYCE® (amikacin liposome inhalation suspension)
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Survey: Management of Arikayce-Associated Respiratory Adverse Events
Amikacin injection or inhalation antibiotic uses, dose & side effects
Oral Inhaled Medications—Beyond Bronchodilators
Presented by : Mina Assaad Metry Under the supervision of : Prof. Dr. Seham Hafez. - ppt download
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE
Amikacin Liposome Dosage Guide + Max Dose, Adjustments - Drugs.com
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
Mechanism of Action | ARIKAYCE® (amikacin liposome inhalation suspension)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
ARIKAYCE® (amikacin liposome inhalation suspension) | Official Patient Site
Neonatal Intensive Care Unit Amikacin Dosage Protocol | Download Scientific Diagram
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
Nebulized antibiotics for treating Ventilator-Associated Pneumonia | PPT
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
Amikacin
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
Inhaled Amikacin Using AeroEclipse® XL BAN (Breath Actuated Nebulizer)
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics
In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text
